Luca Provenzano
Appearances
DateMay 9, 2023BACKGROUND: Gastroesophageal reflux disease (GERD), with or without hiatal hernia (HH), affects millions of individuals worldwide, with a significant economic impact and loss of health-related quality of life…Speakers
University of PadovaPadova University Hospital - Center for Esophageal DiseasesUniversity of PaduaPresenter
- DateMay 9, 2023BACKGROUND: Gastroesophageal reflux disease (GERD), with or without hiatal hernia (HH), affects millions of individuals worldwide, with a significant economic impact and loss of health-related quality of life…
Presenter
Speakers
University of PadovaPadova University Hospital - Center for Esophageal DiseasesUniversity of Padua - DateMay 6, 2023Laparoscopic fundoplication in patients with a history of lung transplant has an average length of stay (LOS) of 3 days with a 30-day readmission rate of 25%, which is significantly worse compared to the non-lung transplant population…
Presenter
Speakers
University of PadovaPadova University Hospital - Center for Esophageal Diseases - DateMay 8, 2023Toupet fundoplication (TF) has been shown to have fewer adverse effects compared to Nissen fundoplication (NF), however, it is unknown whether the advantages of TF persist when comparing outcomes by the distensibility of post-fundoplication lower esophageal sphincter (LES)…
Speakers
Padova University Hospital - Center for Esophageal DiseasesUniversity of PaduaUniversity of PadovaPresenter
- DateMay 9, 2023The aim of this study was to assess the association between interval between nCRT and
Presenter
Speakers
University of PadovaPadova University Hospital - Center for Esophageal DiseasesUniversity of Padua - DateMay 6, 2023LUNCH AND TRAINEE JEOPARDY! 12:00 PM - 1:00 PM LEADERSHIP FORUM, NETWORKING SESSION AND ROUNDTABLES 4:00 PM - 5:30 PM KEYNOTE ADDRESS: FUTURE SCENARIO PLANNING TO PREDICT THE FUTURE OF SURGERY 4:00 PM - 4:30 PM
Speakers
Padova University Hospital - Center for Esophageal DiseasesUniversity of PaduaUniversity of PadovaPresenter
- DateMay 20, 2024BACKGROUND: The gold-standard treatment for esophago-gastric junction outflow obstruction (EGJOO) is still debated…
Presenter
Speakers
University of PadovaUniversity of PaduaPadova University Hospital - Center for Esophageal Diseases - DateMay 19, 2024BACKGROUND: Pathophysiology of GERD is complex and esophageal motility disorders are frequently contributing to the disease…
Presenter
Speakers
Padova University Hospital - Center for Esophageal DiseasesUniversity of Padova - DateMay 21, 2024BACKGROUND: After improving the original technique a few years ago, transoral septotomy has become the favored approach of Zenker Diverticulum (ZD) treatment…
Presenter
Speakers
University of PadovaPadova University Hospital - Center for Esophageal Diseases - DateMay 21, 2024There is no consensus on the definition of failure after treatment in patients with esophageal achalasia. Indeed, the Eckardt score (ES) is commonly used to define clinical outcome, but objective metrics based on high-resolution manometry (HRM) or other diagnostic methods are lacking…
Presenter
Speakers
University of PadovaPadova University Hospital - Center for Esophageal Diseases - DateMay 21, 2024Two multimodal strategies are available for the treatment of esophageal cancer: neoadjuvant chemotherapy (nCT) and chemoradiotherapy (nCRT). The higher rate of pathological complete response (pCR) after nCRT is an argument to support this treatment…
Presenter
Speakers
University of PadovaPadova University Hospital - Center for Esophageal Diseases 
DateMay 18, 2024RISK FACTORS FOR REGROWTH AFTER NONOPERATIVE MANAGEMENT FOR RECTAL CANCERModerators
Stony Brook University HospitalCleveland ClinicUniversity of Wisconsin-MadisonUniversity of Alabama at Birmingham (UAB)Speakers
Massachusetts General Hospital
